Cargando…
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis
Intestinal microbiota dysbiosis is an established characteristic of ulcerative colitis (UC). Regulating the gut microbiota is an attractive alternative UC treatment strategy, considering the potential adverse effects of synthetic drugs used to treat UC. Kaempferol (Kae) is an anti-inflammatory and a...
Autores principales: | Qu, Yifan, Li, Xinyi, Xu, Fengying, Zhao, Shimin, Wu, Xuemei, Wang, Yuzhen, Xie, Jiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339999/ https://www.ncbi.nlm.nih.gov/pubmed/34367139 http://dx.doi.org/10.3389/fimmu.2021.679897 |
Ejemplares similares
-
Tacrolimus alleviates LPS‐induced AKI by inhibiting TLR4/MyD88/NF‐κB signalling in mice
por: Hu, Xueqing, et al.
Publicado: (2021) -
PEP-sNASP Peptide Alleviates LPS-Induced Acute Lung Injury Through the TLR4/TRAF6 Axis
por: Wu, Yu-Chih, et al.
Publicado: (2022) -
Kaempferol exerts a neuroprotective effect to reduce neuropathic pain through TLR4/NF‐ĸB signaling pathway
por: Chang, Shiquan, et al.
Publicado: (2022) -
Kaempferol Alleviates the Interleukin-1β-Induced Inflammation in Rat Osteoarthritis Chondrocytes via Suppression of NF-κB
por: Zhuang, Zhengling, et al.
Publicado: (2017) -
Silencing of PTX3 alleviates LPS-induced inflammatory pain by regulating TLR4/NF-κB signaling pathway in mice
por: Qi, Shuang, et al.
Publicado: (2020)